295 related articles for article (PubMed ID: 16469084)
1. Granulomas induced by subcutaneous injection of leuprorelin acetate.
Sakamoto R; Higashi Y; Mera K; Kanekura T; Kanzaki T
J Dermatol; 2006 Jan; 33(1):43-5. PubMed ID: 16469084
[TBL] [Abstract][Full Text] [Related]
2. Leuprorelin acetate granulomas: case reports and review of the literature.
Yasukawa K; Sawamura D; Sugawara H; Kato N
Br J Dermatol; 2005 May; 152(5):1045-7. PubMed ID: 15888168
[TBL] [Abstract][Full Text] [Related]
3. [Cutaneous epithelioid granulomas caused by subcutaneous infusion of leuprorelin acetate: a case report].
Tachibana M; Yamano Z; Kusuda Y; Hara S; Shimogaki H; Hamami G
Hinyokika Kiyo; 2004 Mar; 50(3):199-202. PubMed ID: 15148774
[TBL] [Abstract][Full Text] [Related]
4. Injection-site granulomas due to the administration of leuprorelin acetate for the treatment of prostatic cancer.
Shiota M; Tokuda N; Kanou T; Yamasaki H
Fukuoka Igaku Zasshi; 2007 Jul; 98(7):301-4. PubMed ID: 17710895
[TBL] [Abstract][Full Text] [Related]
5. [Surgical management of inflammatory granuloma which developed following subcutaneous injection of leuprorelin acetate: a case report].
Oida T; Shichiri Y; Takao N; Kanno T; Kanamaru H
Hinyokika Kiyo; 2005 Jul; 51(7):487-9. PubMed ID: 16119817
[TBL] [Abstract][Full Text] [Related]
6. A morphological study of granulomas induced by subcutaneous injection of leuprorelin acetate.
Watanabe T; Yamada N; Yoshida Y; Yamamoto O
J Cutan Pathol; 2009 Dec; 36(12):1299-302. PubMed ID: 19469875
[TBL] [Abstract][Full Text] [Related]
7. [Skin reaction induced by subcutaneous injection of LH-RH analogue].
Segawa N; Nishida T; Hamada S; Azuma H; Katsuoka Y; Nozaki K; Tsuji M
Hinyokika Kiyo; 2007 Oct; 53(10):695-8. PubMed ID: 18018584
[TBL] [Abstract][Full Text] [Related]
8. Granuloma caused by subcutaneous injection of leuprorelin acetate product: case report and histopathological findings.
Ouchi T; Koyama T; Miyata N; Sugiura M
J Dermatol; 2006 Oct; 33(10):719-21. PubMed ID: 17040504
[TBL] [Abstract][Full Text] [Related]
9. [Granulomas induced by injections of leuprorelin acetate (Enantone®)].
Bruneu-Avierinos Y; Monestier S; Tasei AM; Gaudy-Marqueste C; Grob JJ; Richard MA
Ann Dermatol Venereol; 2011 Jan; 138(1):35-7. PubMed ID: 21276459
[TBL] [Abstract][Full Text] [Related]
10. Noninfective cutaneous granuloma with leuprorelin acetate--reality or myth.
Dangle P; Palit V; Sundaram SK; Weston P
Urology; 2007 Apr; 69(4):779.e5-6. PubMed ID: 17445679
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous granulomas caused by subcutaneous injections of leuprorelin acetate.
Kluger N; Hahtola S; Lempinen T; Jeskanen L
Presse Med; 2017 Oct; 46(10):966-968. PubMed ID: 28919272
[No Abstract] [Full Text] [Related]
12. Randomised crossover trial to assess the tolerability of LHRH analogue administration.
Williams G; Lindsay S; Bowsher WG
Prostate Cancer Prostatic Dis; 2003; 6(2):187-9. PubMed ID: 12806381
[TBL] [Abstract][Full Text] [Related]
13. Resistance to luteinizing hormone releasing hormone agonist therapy for metastatic prostate cancer.
Curry EA; Sweeney CJ
J Urol; 2002 Jul; 168(1):193. PubMed ID: 12050525
[No Abstract] [Full Text] [Related]
14. Granulomas induced by subcutaneous injection of a luteinizing hormone-releasing hormone analog: a case report and review of the literature.
Watanabe T; Yamada N; Yoshida Y; Yamamoto O
J Cutan Pathol; 2010 Oct; 37(10):1116-8. PubMed ID: 19863702
[No Abstract] [Full Text] [Related]
15. Incidence rate of injection-site granulomas resulting from the administration of luteinizing hormone-releasing hormone analogues for the treatment of prostatic cancer.
Shiota M; Tokuda N; Kanou T; Yamasaki H
Yonsei Med J; 2007 Jun; 48(3):421-4. PubMed ID: 17594149
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of incidence and risk factors of subcutaneous granulomas induced by injection of leuprorelin acetate].
Fukui S; Nakai Y; Matsumoto Y; Kagebayashi Y; Samma S
Hinyokika Kiyo; 2015 Feb; 61(2):55-9. PubMed ID: 25812594
[TBL] [Abstract][Full Text] [Related]
17. A case of foreign body granuloma induced by subcutaneous injection of leuprorelin acetate─clinical analysis for 335 cases in our hospital─.
Kawai M; Ikoma N; Yamada A; Ota T; Manabe Y; Kato M; Mabuchi T; Ozawa A; Higure T; Terachi T
Tokai J Exp Clin Med; 2014 Sep; 39(3):106-10. PubMed ID: 25248424
[TBL] [Abstract][Full Text] [Related]
18. Injection-site granulomas resulting from the administration of both leuprorelin acetate and goserelin acetate for the treatment of prostatic cancer.
Shiota M; Tokuda N; Kanou T; Yamasaki H
J Nippon Med Sch; 2007 Aug; 74(4):306-8. PubMed ID: 17878701
[TBL] [Abstract][Full Text] [Related]
19. Leuprorelin acetate granulomas: recurrent subcutaneous nodules mimicking metastatic deposits at injection sites.
Whitaker IS; Fazel MZ; Joshi HB; Moseley RP; Turner WH
BJU Int; 2002 Aug; 90(3):350. PubMed ID: 12133078
[No Abstract] [Full Text] [Related]
20. Discovery of a pituitary adenoma following treatment with a gonadotropin-releasing hormone agonist in a patient with prostate cancer.
Massoud W; Paparel P; Lopez JG; Perrin P; Daumont M; Ruffion A
Int J Urol; 2006 Jan; 13(1):87-8. PubMed ID: 16448441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
